Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2015-07-30
Product name
ALVERIN PLUS; LEVATUM
Product Synonyms
Ivermectin and Clorsulon Injection; Alverin; Levatum/Alverin Plus Solution; Levatum D; Levatum Plus; Levatum Super; Levatum/Alverin Plus 10/100 mg/ml
Chemical name
Avermectin macrocyclic lactone , Benzenesulfonamide
Icons in SDS
Company Information
company name
Zoetis Inc
e-mail address of the competent person responsible for the Safety Data Sheet
VMIPSrecords@zoetis.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H361, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Appearance: Clear pale yellow to yellow liquid
2.1 Classification of the substance or mixture
Acute Oral Toxicity: Category 4 Reproductive Toxicity: Category 2 Acute aquatic toxicity: Category 1 Chronic aquatic toxicity: Category 1
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed H361 - Suspected of damaging fertility or the unborn child H410 - Very toxic to aquatic life with long lasting effects
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P264 - Wash hands thoroughly after handling P270 - Do not eat, drink or smoke when using this product P273 - Avoid release to the environment P308 + P313 - IF exposed or concerned: Get medical attention/advice P301+ P312 - IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell P330 - Rinse mouth P391 - Collect spillage P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
Short Term: May cause eye and skin irritation (based on components) . Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on developing fetus. May cause effects in cardiovascular system, nervous system , liver, heart, and skin through prolonged or repeated exposure. Known Clinical Effects: Cases of severe overdose may lead to swelling, allergic skin rash, headache, dizziness, weakness, nausea, vomiting, diarrhea, seizure, clumsy motion of limbs/trunk (ataxia), shortness of breath (dyspnea) abdominal discomfort. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
